U.S. flag

An official website of the United States government

NM_000260.4(MYO7A):c.1849T>C (p.Ser617Pro) AND Autosomal recessive nonsyndromic hearing loss 2

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
May 22, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000681537.2

Allele description [Variation Report for NM_000260.4(MYO7A):c.1849T>C (p.Ser617Pro)]

NM_000260.4(MYO7A):c.1849T>C (p.Ser617Pro)

Gene:
MYO7A:myosin VIIA [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q13.5
Genomic location:
Preferred name:
NM_000260.4(MYO7A):c.1849T>C (p.Ser617Pro)
Other names:
NM_000260.4(MYO7A):c.1849T>C
HGVS:
  • NC_000011.10:g.77172799T>C
  • NG_009086.2:g.49554T>C
  • NM_000260.4:c.1849T>CMANE SELECT
  • NM_001127180.2:c.1849T>C
  • NM_001369365.1:c.1816T>C
  • NP_000251.3:p.Ser617Pro
  • NP_001120652.1:p.Ser617Pro
  • NP_001356294.1:p.Ser606Pro
  • LRG_1420t1:c.1849T>C
  • LRG_1420:g.49554T>C
  • LRG_1420p1:p.Ser617Pro
  • NC_000011.9:g.76883845T>C
  • NC_000011.9:g.76883845T>C
  • NG_009086.1:g.49536T>C
  • NM_000260.3(MYO7A):c.1849T>C
  • NM_000260.3:c.1849T>C
  • NM_001127180.1:c.1849T>C
  • p.Ser617Pro
Protein change:
S606P
Links:
dbSNP: rs782063761
NCBI 1000 Genomes Browser:
rs782063761
Molecular consequence:
  • NM_000260.4:c.1849T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127180.2:c.1849T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369365.1:c.1816T>C - missense variant - [Sequence Ontology: SO:0001583]
Observations:
2

Condition(s)

Name:
Autosomal recessive nonsyndromic hearing loss 2
Synonyms:
NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 2; Deafness, autosomal recessive 2
Identifiers:
MONDO: MONDO:0010807; MedGen: C1838701; Orphanet: 90636; OMIM: 600060

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000807729National Institute on Deafness and Communication Disorders, National Institutes of Health
no assertion criteria provided
Pathogenic
(Jul 5, 2018)
germlineresearch

SCV0025212423billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(May 22, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes2not providednot provided2yesresearch, clinical testing

Citations

PubMed

Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease.

Carss KJ, Arno G, Erwood M, Stephens J, Sanchis-Juan A, Hull S, Megy K, Grozeva D, Dewhurst E, Malka S, Plagnol V, Penkett C, Stirrups K, Rizzo R, Wright G, Josifova D, Bitner-Glindzicz M, Scott RH, Clement E, Allen L, Armstrong R, Brady AF, et al.

Am J Hum Genet. 2017 Jan 5;100(1):75-90. doi: 10.1016/j.ajhg.2016.12.003. Epub 2016 Dec 29.

PubMed [citation]
PMID:
28041643
PMCID:
PMC5223092

Genetic Spectrum of Syndromic and Non-Syndromic Hearing Loss in Pakistani Families.

Doll J, Vona B, Schnapp L, Rüschendorf F, Khan I, Khan S, Muhammad N, Alam Khan S, Nawaz H, Khan A, Ahmad N, Kolb SM, Kühlewein L, Labonne JDJ, Layman LC, Hofrichter MAH, Röder T, Dittrich M, Müller T, Graves TD, Kong IK, Nanda I, et al.

Genes (Basel). 2020 Nov 11;11(11). doi:pii: E1329. 10.3390/genes11111329.

PubMed [citation]
PMID:
33187236
PMCID:
PMC7709052
See all PubMed Citations (3)

Details of each submission

From National Institute on Deafness and Communication Disorders, National Institutes of Health, SCV000807729.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providedyesresearchnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

From 3billion, SCV002521242.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (3)

Description

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.001%). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.92; 3Cnet: 0.86). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with MYO7A related disorder (ClinVar ID: VCV000438172 / PMID: 28041643). The variant has been reported to be in trans with a pathogenic variant as either compound heterozygous or homozygous in at least one similarly affected unrelated individual (PMID: 33187236) and co-segregate with the disease in at least one similarly affected relative/individual in the same family or similarly affected unrelated family (PMID: 33187236). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024